rs2236556
Variant names: 
Your query was ambiguous. Multiple possible variants found: 
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_145868.2(ANXA11):c.-8-165A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000176 in 453,708 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: not found (cov: 34) 
 Exomes 𝑓:  0.000018   (  0   hom.  ) 
Consequence
 ANXA11
NM_145868.2 intron
NM_145868.2 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  0.0820  
Publications
4 publications found 
Genes affected
 ANXA11  (HGNC:535):  (annexin A11) This gene encodes a member of the annexin family, a group of calcium-dependent phospholipid-binding proteins. Annexins have unique N-terminal domains and conserved C-terminal domains, which contain calcium-dependent phospholipid-binding sites. The encoded protein is a 56-kD antigen recognized by sera from patients with various autoimmune diseases. Several transcript variants encoding two different isoforms have been identified. [provided by RefSeq, Dec 2015] 
ANXA11 Gene-Disease associations (from GenCC):
- amyotrophic lateral sclerosis type 23Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- inclusion body myopathy and brain white matter abnormalitiesInheritance: AD Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- amyotrophic lateral sclerosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84). 
BS2
High AC in GnomAdExome4 at 8 AD gene. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD3 genomes 
Cov.: 
34
GnomAD4 exome  AF:  0.0000176  AC: 8AN: 453708Hom.:  0  Cov.: 5 AF XY:  0.00000837  AC XY: 2AN XY: 239048 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
8
AN: 
453708
Hom.: 
Cov.: 
5
 AF XY: 
AC XY: 
2
AN XY: 
239048
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
11794
American (AMR) 
 AF: 
AC: 
0
AN: 
18282
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
13410
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
28974
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
46398
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
30050
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
2738
European-Non Finnish (NFE) 
 AF: 
AC: 
7
AN: 
276206
Other (OTH) 
 AF: 
AC: 
1
AN: 
25856
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.475 
Heterozygous variant carriers
 0 
 1 
 1 
 2 
 2 
 3 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  
GnomAD4 genome 
Cov.: 
34
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.